x
Peter Anastasiou
Executive Vice President and Head Of North America
Lundbeck
Peter Anastasiou
Executive Vice President and Head Of North America

x
Shideh Bina
Founding Partner
Insigniam
Shideh Bina
Founding Partner

x
Paula Brown Stafford
Managing director
Habergeon, LLC
Paula Brown Stafford
Managing director

x
Nick Colucci
Executive Chairman, Publicis Health & COO, Publicis Communications North America
Publicis Health
Nick Colucci
Executive Chairman, Publicis Health & COO, Publicis Communications North America

x
Joaquin Duato
EVP & Worldwide Chairman, Pharmaceuticals
Johnson & Johnson
Joaquin Duato
EVP & Worldwide Chairman, Pharmaceuticals

x
Lisa George
Chief Human Resources Officer
Shearer's Snacks
Lisa George
Chief Human Resources Officer

x
Julie Gerberding
Executive Vice President and Chief Patient Officer
Merck & Co., Inc.
Julie Gerberding
Executive Vice President and Chief Patient Officer

x
Geno Germano
president & CEO
Elucida Oncology
Geno Germano
president & CEO

x
Brian Goff
Chief Commercial Officer
Alexion Pharmaceuticals, Inc.
Brian Goff
Chief Commercial Officer

x
Murdo Gordon
Executive Vice President of Global Commercial Operations
Amgen Inc.
Murdo Gordon
Executive Vice President of Global Commercial Operations

x
Adele Gulfo
Chief of Commercial Development
Roivant Sciences
Adele Gulfo
Chief of Commercial Development

x
Bahija Jallal
President; and executive vice president, AstraZeneca, 2017 HBA Woman of the Year
MedImmune
Bahija Jallal
President; and executive vice president, AstraZeneca, 2017 HBA Woman of the Year

x
Jacopo Leonardi
Chairman and CEO
ActivCore
Jacopo Leonardi
Chairman and CEO

x
Christine Miller
Head Global Portfolio
Sandoz
Christine Miller
Head Global Portfolio

x
Carol Montandon
Chief Quality Officer, Vice President Quality and Compliance
Johnson & Johnson
Carol Montandon
Chief Quality Officer, Vice President Quality and Compliance

x
Terri Pascarelli
Chief executive officer
AIT Bioscience
Terri Pascarelli
Chief executive officer

x
Mary Pittman
President & CEO
Public Health Institute
Mary Pittman
President & CEO

x
Pamela Puryear
Senior vice president, chief talent officer
Pfizer Inc.
Pamela Puryear
Senior vice president, chief talent officer

x
Kim Ramko
Americas Advisory Life Sciences Sector Lead
EY
Kim Ramko
Americas Advisory Life Sciences Sector Lead

x
Kevin Rigby
Principal
Rigby Consulting LLC
Kevin Rigby
Principal

x
Christi Shaw
President, bio-medicines
Eli Lilly and Company
Christi Shaw
President, bio-medicines

x
Ruth Williams-Brinkley
President, Kaiser Permanente Health Plan and Hospitals of the Northwest
Kaiser Permanente
Ruth Williams-Brinkley
President, Kaiser Permanente Health Plan and Hospitals of the Northwest

x
Tim Zuber
Partner
KPMG LLP
Tim Zuber
Partner

Advisory Board Committee

x
Laurie Cooke
President & chief executive officer
Healthcare Businesswomen's Association
Laurie Cooke
President & chief executive officer

Laurie Cooke is the president and CEO of the HBA. Laurie is a dedicated advocate for gender parity, speaker, thought leader, PharmaVOICE 100 most inspiring people in life sciences and ASAE Mentor of the Year. Laurie served on PMI’s executive management team; and prior to nonprofit management work, she served in increasing senior roles ex-US with Hoechst, Hoechst Roussel, Hoechst Marion Roussel, and Aventis working across all pre-clinical to post approval areas including phase I biometrics, project management, process improvement, and late stage team effectiveness. Laurie began her career as a head hospital pharmacist in Washington State. Laurie graduated with a degree in microbiology from University of Maryland, advanced scientific degree in pharmacy from University of Washington, masters in Software Engineering Management from University of Luton, England. She is a licensed pharmacist and certified association executive. Laurie has lived and worked in Europe, New Zealand and both US coasts and currently lives in the Philadelphia main line with her husband and four active pets.
x
Rhonda Johnson
EVP
Market Performance Group
Rhonda Johnson
EVP

x
Shannon Resetich
head of rare disease & rare blood disorders , North America
Sanofi Genzyme
Shannon Resetich
head of rare disease & rare blood disorders , North America

Shannon Resetich leads the North America Rare Disease and Rare Blood Disorders franchises for Sanofi Genzyme. She is responsible for driving the growth of these franchises and enabling the company to reach those patients who may benefit from Sanofi Genzyme’s therapies. Shannon is responsible for all U.S. commercial activities for the Rare Diseases and Rare Blood Disorders franchises inclusive of sales, marketing and patient and provider services. Shannon has an exceptional track record of creating sustainable success and elevating standards of care for patients with rare diseases and specialty conditions. She has more than 20 years of experience leading cross-functional teams in the pharmaceutical, healthcare, and consumer packaged goods sectors. Shannon joined Sanofi Genzyme in March of 2018 from Activcore, a start-up concierge physical and performance therapy organization where she served as Board Director, EVP & Chief Commercial Officer. Prior to joining Activcore, Shannon was Global Franchise Head, Hematology at Shire, where she was responsible for increasing growth of the $3.6 billion franchise. Prior to Shire’s acquisition of Baxalta, Shannon held positions of increasing responsibility for more than 10 years at Baxter/Baxalta across their Hematology and Pulmonary business. These positions included Region Head, North America Hematology, and U.S. Head, Hematology. Prior to joining Baxter, Shannon spent multiple years in R&D and brand development with Kraft Foods. For the past four years, Shannon has served on the Board of Directors of the Healthcare Businesswomen’s Association (HBA) and she is currently the Chair of the Board. She is a former member of the Board of Directors for the Illinois Biotechnology Innovation Organization (iBIO). Shannon received her MBA from the Kellogg School of Management at Northwestern University and her undergraduate degree in biological engineering from Purdue University.
x
Rebecca Vermeulen
head, customer strategy and patient partnership, global medical affairs
Genentech, Inc.
Rebecca Vermeulen
head, customer strategy and patient partnership, global medical affairs

Rebecca Vermeulen R.Ph. brings a variety of experiences and capabilities to her role as Customer Strategy and Patient Partnership for Global Medical Affairs at Roche. She has spent 26 years in the pharmaceutical industry and has served in a variety of functions including Medical Affairs, Clinical Research, Sales, Medical Communications, Medical Science Liaisons, Patient Partnership, Digital Health, and Six Sigma. Rebecca has lead teams spanning multiple organizational units and has been responsible for creating global standards for information exchange with healthcare professionals and patients. She has served as a senior leader dedicated to empowering patients and HCPs to make informed health decisions for a number of years and knows how to demonstrate value in bringing new medicines to patients. Rebecca is currently Vice-Chair Board of Directors for the DIA (Drug Information Association), Vice-Chair Corporate Board of Directors for the HBA (Healthcare Businesswomen’s Association), and serves on the Advisory Committee for PFMD (Patient Focused Medicine Development).
x
Wendy White
Principal consultant and past HBA president
Wendy White Consulting
Wendy White
Principal consultant and past HBA president

x
Chair
Erica Zeplin - Pratt
EMD Serono, Inc.
Chair
Erica Zeplin - Pratt